[1]Leatherbury, L.; Chandra, R. S.; Shapiro, S. R. und Perry, L. W. (1988): Value of endomyocardial biopsy in infants, children and adolescents with dilated or hypertrophic cardiomyopathy and myocarditis, J-Am-Coll-Cardiol (Band 12), Nr. 6, Seite 1547-54.

[2]Kasper, E. K.; Agema, W. R.; Hutchins, G. M.; Deckers, J. W.; Hare, J. M. und Baughman, K. L. (1994): The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients [see comments], J-Am-Coll-Cardiol (Band 23), Nr. 3, Seite 586-90.

[3]McKenna, W. J.; Thiene, G.; Nava, A.; Fontaliran, F.; Blomstrom Lundqvist, C.; Fontaine, G. und Camerini, F. (1994): Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology, Br-Heart-J (Band 71), Nr. 3, Seite 215-8.

[4]Corrado, D.; Basso, C.; Thiene, G.; McKenna, W. J.; Davies, M. J.; Fontaliran, F.; Nava, A.; Silvestri, F.; Blomstrom Lundqvist, C.; Wlodarska, E. K.; Fontaine, G. und Camerini, F. (1997): Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study, J-Am-Coll-Cardiol (Band 30), Nr. 6, Seite 1512-20.

[5]Fontaliran, F.; Arkwright, S.; Vilde, F. und Fontaine, G. (1998): [Arrhythmogenic right ventricular dysplasia and cardiomyopathy. Clinical and anatomic-pathologic aspects, nosologic approach], Arch Anat Cytol Pathol (Band 46), Nr. 3, Seite 171-7.

[6]Kawai, Chuichi (1999): From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death : Learning From the Past for the Future, Circulation (Band 99), Nr. 8, Seite 1091-1100. URL:

[7]Swain, S. M. (1998): Adult multicenter trials using dexrazoxane to protect against cardiac toxicity, Semin Oncol (Band 25), Nr. 4 Suppl 10, Seite 43-7. URL:

[8]Gaudin, P. B.; Hruban, R. H.; Beschorner, W. E.; Kasper, E. K.; Olson, J. L.; Baughman, K. L. und Hutchins, G. M. (1993): Myocarditis associated with doxorubicin cardiotoxicity, Am J Clin Pathol (Band 100), Nr. 2, Seite 158-63. URL:

[9]Patz, S. (1986): Basic physics of nuclear magnetic resonance, Cardiovasc Intervent Radiol (Band 8), Nr. 5-6, Seite 225-37. URL:

[10]Gottdiener, J. S.; Livengood, S. V.; Meyer, P. S. und Chase, G. A. (1995): Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function, J-Am-Coll-Cardiol (Band 25), Nr. 2, Seite 424-30.

[11]Kupferwasser, I.; Mohr Kahaly, S.; Stahr, P.; Rupprecht, H. J.; Nixdorff, U.; Fenster, M.; Voigtlander, T.; Erbel, R. und Meyer, J. (1997): Transthoracic three-dimensional echocardiographic volumetry of distorted left ventricles using rotational scanning, J-Am-Soc-Echocardiogr (Band 10), Nr. 8, Seite 840-52.

[12]Chuang, M. L.; Hibberd, M. G.; Salton, C. J.; Beaudin, R. A.; Riley, M. F.; Parker, R. A.; Douglas, P. S. und Manning, W. J. (2000): Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging, J Am Coll Cardiol (Band 35), Nr. 2, Seite 477-84.

[13]Lieback E, Hardouin I, Meyer R, Bellach J ,Hetzer R (1996): Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis, Eur Herat J (Band 17), Seite 135-142.

[14]Jacobus, W. E.; Taylor, G. J. th; Hollis, D. P. und Nunnally, R. L. (1977): Phosphorus nuclear magnetic resonance of perfused working rat hearts, Nature (Band 265), Nr. 5596, Seite 756-8. URL:

[15]Neubauer, S. (2000): Cardiac magnetic resonance spectroscopy: potential clinical applications, Herz (Band 25), Nr. 4, Seite 452-60. URL:

[16]Auffermann, W.; Wichter, T.; Breithardt, G.; Joachimsen, K. und Peters, P. E. (1993): Arrhythmogenic right ventricular disease: MR imaging vs angiography, AJR-Am-J-Roentgenol (Band 161), Nr. 3, Seite 549-55.

[17]Blake, L. M.; Scheinman, M. M. und Higgins, C. B. (1994): MR features of arrhythmogenic right ventricular dysplasia, AJR-Am-J-Roentgenol (Band 162), Nr. 4, Seite 809-12.

[18]Kim, R. J.; Wu, E.; Rafael, A.; Chen, E. L.; Parker, M. A.; Simonetti, O.; Klocke, F. J.; Bonow, R. O. und Judd, R. M. (2000): The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction, N Engl J Med (Band 343), Nr. 20, Seite 1445-1453. URL:

[19]Simonetti, O. P.; Finn, J. P.; White, R. D.; Laub, G. und Henry, D. A. (1996): "Black blood" T2-weighted inversion-recovery MR imaging of the heart, Radiology (Band 199), Nr. 1, Seite 49-57.

[20]Friedrich, M. G.; Strohm, O.; Schulz Menger, J.; Marciniak, H.; Luft, F. C. und Dietz, R. (1999): Noninvasive diagnosis of acute myocarditis by contrast-enhanced magnetic resonance imaging - response to the author, Circulation (Band 99), Seite 459-460 (letter).

[21]Ogawa, S.; Lee, T. M.; Kay, A. R. und Tank, D. W. (1990): Brain magnetic resonance imaging with contrast dependent on blood oxygenation, Proc-Natl-Acad-Sci-U-S-A (Band 87), Nr. 24, Seite 9868-72.

[22]Plein, S.; Bloomer, T. N.; Ridgway, J. P.; Jones, T. R.; Bainbridge, G. J. und Sivananthan, M. U. (2001): Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging, J Magn Reson Imaging (Band 14), Nr. 3, Seite 230-6. URL:

[23]Brasch, R. C.; Weinmann, H. J. und Wesbey, G. E. (1984): Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex, AJR-Am-J-Roentgenol (Band 142), Nr. 3, Seite 625-30 *LHM: This title is not owned by this library ISSN: 0361-803X.

[24]Shellock, F. G.; Schaefer, D. J.; Grundfest, W. und Crues, J. V. (1986): Thermal effects of high-field (1.5 tesla) magnetic resonance imaging of the spine. Clinical experience above a specific absorption rate of 0.4 W/kg, Acta Radiol Suppl (Band 369), Seite 514-6. URL:

[25]Weikl, A.; Moshage, W.; Hentschel, D.; Schittenhelm, R. und Bachmann, K. (1989): [ECG changes caused by the effect of static magnetic fields of nuclear magnetic resonance tomography using magnets with a field power of 0.5 to 4.0 Telsa], Z Kardiol (Band 78), Nr. 9, Seite 578-86. URL:

[26]Achenbach, S.; Moshage, W.; Diem, B.; Bieberle, T.; Schibgilla, V. und Bachmann, K. (1997): Effects of magnetic resonance imaging on cardiac pacemakers and electrodes, Am Heart J (Band 134), Nr. 3, Seite 467-73. URL:

[27]Friedrich, M.G.; Strohm, O.; D., Kivelitz; Gross, W.; Wagner, A.; Schulz-Menger, J.; Liu, X.; Hamm, B. und Dietz, R. (1999): Behaviour of implantable coronary stents during magnetic resonance imaging, Int J Cardiovasc Int (Band 2), Nr. 4, Seite 217-222.

[28]Hug, J.; Nagel, E.; Bornstedt, A.; Schnackenburg, B.; Oswald, H. und Fleck, E. (2000): Coronary arterial stents: safety and artifacts during MR imaging, Radiology (Band 216), Nr. 3, Seite 781-7. URL:

[29]Francis, J. M. und Pennell, D. J. (2000): Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation, J Cardiovasc Magn Reson (Band 2), Nr. 2, Seite 139-41. URL:

[30]Friedrich MG; Schulz-Menger J; Lankes W; Poetsch T und R., Dietz (2001): The safety of cardiovascular magnetic resonance - a single-center experience in more than 2500 cases., J Am Coll Cardiol (Band (abstract, in press)).

[31]Pruessmann, K. P.; Weiger, M.; Scheidegger, M. B. und Boesiger, P. (1999): SENSE: sensitivity encoding for fast MRI, Magn Reson Med (Band 42), Nr. 5, Seite 952-62. URL:

[32]Friedrich, M.; Weikl, A.; Sauter, R.; Reinhardt, E. R. und Bachmann, K. (1991): [Localized 31 phosphorus NMR spectroscopy of the human heart-- development of a measuring method and initial clinical application], Z Kardiol (Band 80), Nr. 4, Seite 266-71. URL:

[33]Osterziel, K. J.; Strohm, O.; Schuler, J.; Friedrich, M.; Hanlein, D.; Willenbrock, R.; Anker, S. D.; Poole Wilson, P. A.; Ranke, M. B. und Dietz, R. (1998): Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy, Lancet (Band 351), Nr. 9111, Seite 1233-7.

[34]Friedrich, M. G.; Strohm, O.; Osterziel, K. J. und Dietz, R. (1998): Growth hormone therapy in dilated cardiomyopathy monitored with MRI, Magma (Band 6), Nr. 2-3, Seite 152-4.

[35]Benjelloun, H.; Cranney, G. B.; Kirk, K. A.; Blackwell, G. G.; Lotan, C. S. und Pohost, G. M. (1991): Interstudy reproducibility of biplane cine nuclear magnetic resonance measurements of left ventricular function, Am-J-Cardiol (Band 67), Nr. 16, Seite 1413-20.

[36]Friedrich MG; Schulz-Menger J; Strohm O; Dick AJ und R., Dietz (2000): The diagnostic impact of 2D- versus 3D left ventricular volumetry by MRI in patients with suspected heart failure, MAGMA (Band 11), Seite 16-19.

[37]Strohm, O.; Schulz-Menger, J.; Pilz, B.; Osterziel, K. J.; Dietz, R. und Friedrich, M. G. (2001): Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy, J Magn Reson Imaging (Band 13), Nr. 3, Seite 367-71. URL:

[38]Bottini, P. B.; Carr, A. A.; Prisant, L. M.; Flickinger, F. W.; Allison, J. D. und Gottdiener, J. S. (1995): Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient, Am-J-Hypertens (Band 8), Nr. 3, Seite 221-8.

[39]Missouris, C. G.; Forbat, S. M.; Singer, D. R.; Markandu, N. D.; Underwood, R. und MacGregor, G. A. (1996): Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension, J-Hypertens (Band 14), Nr. 8, Seite 1005-10.

[40]Posma, J. L.; Blanksma, P. K.; van der Wall, E. E.; Hamer, H. P.; Mooyaart, E. L. und Lie, K. I. (1996): Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: magnetic resonance imaging versus echocardiography, Am-Heart-J (Band 132), Nr. 5, Seite 1020-7.

[41]Pons Llado, G.; Carreras, F.; Borras, X.; Palmer, J.; Llauger, J. und Bayes de Luna, A. (1997): Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging, Am-J-Cardiol (Band 79), Nr. 12, Seite 1651-6.

[42]Soler, R.; Rodriguez, E.; Rodriguez, J. A.; Perez, M. L. und Penas, M. (1997): Magnetic resonance imaging of apical hypertrophic cardiomyopathy, J-Thorac-Imaging (Band 12), Nr. 3, Seite 221-5.

[43]Pongratz, G.; Friedrich, M.; Unverdorben, M.; Kunkel, B. und Bachmann, K. (1991): Hypertrophic obstructive cardiomyopathy as a manifestation of a cardiocutaneous syndrome (Noonan syndrome), Klin-Wochenschr (Band 69), Nr. 20, Seite 932-6.

[44]Strohm, O.; Schulz-Menger, J.; Hanlein, D.; Dietz, R. und Friedrich, M. G. (2001): Magnetic resonance planimetry of the vena contracta as a new approach to assessment of stenotic heart valves: An in vitro study, J Magn Reson Imaging (Band 14), Nr. 1, Seite 31-4. URL:

[45]Friedrich MG; Schulz-Menger J; Poetsch T; Pilz B; Uhlich F und R, Dietz (2002): Quantification of valvular aortic stenosis by magnetic resonance imaging, Am Heart J (Band 144), Seite 329-334.

[46]Schulz-Menger, J.; Strohm, O.; Waigand, J.; Uhlich, F.; Dietz, R. und Friedrich, M. G. (2000): The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization, Circulation (Band 101), Nr. 15, Seite 1764-6. URL:

[47]Friedrich, M.G.; Strohm, O.; Schulz-Menger, J.; Thierfelder, L. und Dietz, R. (1998): Evidence for a low specificity of right ventricular morphological changes related to arrhythmogenic right ventricular cardiomyopathy as assessed by magnetic resonance imaging, Circulation (Band 98), Nr. 17, I, Seite 857(abstract).

[48]Friedrich, M.G. (2000): Magnetic Resonance in Cardiomyopathies, J Cardiovasc Magn Res (Band 2), Nr. 1, Seite 67-82.

[49]Abelmann, WH (1966): Myocarditis, N Engl J Med (Band 275), Nr. 17, Seite 944-5.

[50]Woodruff, JF (1980): Viral myocarditis. A review, Am J Pathol (Band 101), Nr. 2, Seite 425-84.

[51]Drory, Y.; Turetz, Y.; Hiss, Y.; Lev, B.; Fisman, E. Z.; Pines, A. und Kramer, M. R. (1991): Sudden unexpected death in persons less than 40 years of age, Am-J-Cardiol (Band 68), Nr. 13, Seite 1388-92.

[52]Gagliardi MG, Bevilacqua, M, di Renzi P, Picardo S, Passariello R, Marcelletti C. (1991): Usefulness of Magnetic Resonance Imaging for Diagnosis of Acute Myocarditis in Infants and Children, and Cormparison with Endomyocardial Biopsy, Am J Card (Band 68), Seite 1089-91.

[53]Friedrich, M. G.; Strohm, O.; Schulz-Menger, J.; Marciniak, H.; Luft, F. C. und Dietz, R. (1998): Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis, Circulation (Band 97), Nr. 18, Seite 1802-9. URL:

[54]Wagner A; Schulz-Menger J; Dietz R und MG., Friedrich Longterm follow-up of patients with acute myocarditis by magnetic resonance imaging, MAGMA (Band in press.).

[55]Schulz-Menger, J.; Strohm, O.; Dietz, R. und Friedrich, M. G. (2000): Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging, Magma (Band 11), Nr. 1-2, Seite 82-3. URL:

[56]Wassmuth, R.; Lentzsch, S.; Erdbruegger, U.; Schulz-Menger, J.; Doerken, B.; Dietz, R. und Friedrich, M. G. (2001): Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study, Am Heart J (Band 141), Nr. 6, Seite 1007-13. URL:

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: